Vitruvian Partners LLP Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001692590

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedTechnology TiltHigh Turnover how tags are computed

Q2 2026 · 8 positions · Total reported value $200.96M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 50.0% · 0 new · 4 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +3.0% · vs SPY +0.9% · Prev Value $200.96M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +9.7% · vs SPY +7.5% · Latest Value $113.31M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2026 13F filing, Vitruvian Partners LLP disclosed 8 equity positions with a combined reported value of $200.96M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Technology Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were MQ ($111.30M), HNGE ($42.05M), XMTR ($17.49M). By sector, the heaviest allocations are Technology 85.9%, Consumer Discretionary 8.7%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+1.7pp), Industrials (+1.7pp) and away from Health Care (-0.9pp), Technology (-2.4pp).

Versus the prior quarter, Vitruvian Partners LLP opened 0 new positions, trimmed 4 and fully exited 0, a turnover rate of 50.0% of positions. The portfolio's overlap with the prior quarter was 88% of names.

The largest new positions opened in Q2 2026 were WSE ($3.35M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • WSE WISE GROUP PLC · $3.35M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Vitruvian Partners LLP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Vitruvian Partners LLP files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 8 positions worth $200.96M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 8 positions · $200.96M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: MQ (MARQETA INC) at 55.4%
  • Average position size: $25.12M

Sector Tilt

  • Information Technology 85.9%
  • Consumer Discretionary 8.7%
  • Health Care 3.8%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 new, 3 reduced
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to maintain a cautiously optimistic stance, with a focus on technology and health care sectors. The slight increase in position weight to new additions and a hold on existing positions suggests a belief in the long-term potential of these sectors, despite a reduction in some holdings. 2. Key Moves: - Added: WSE (WISE GROUP PLC) in Industrials, a new position with a 1.67% weight. - Reduced: HNGE (HINGE HEALTH INC) by 59.5%, XMTR (XOMETRY INC) by 5.6%, and CARG (CARGURUS INC) by 26.0%. - No Change: MQ (MARQETA INC), GLBE (GLOBAL E ONLINE LTD), MXCT (MAXCYTE INC COM), and RXST (RXSIGHT INC COM). 3. Portfolio Structure: The portfolio seems to be actively managed with a sector bias towards technology and health care. The reduction in positions indicates a willingness to trim back on some holdings, possibly due to valuation concerns or performance issues. The addition of WSE suggests a diversification into the industrials sector, possibly to balance the portfolio or capitalize on perceived opportunities. 4. Per-Holding One-Liner: - MQ (MARQETA INC): Fintech payments platform - 'unverified' - HNGE (HINGE HEALTH INC): Digital health platform - 'unverified' - XMTR (XOMETRY INC): Consumer electronics, particularly in gaming - 'unverified' - CARG (CARGURUS INC): Cloud computing and data analytics - 'unverified' - GLBE (GLOBAL E ONLINE LTD): Online marketplace - 'unverified' - MXCT (MAXCYTE INC COM): Biotechnology, focusing on cell culture - 'unverified' - WSE (WISE GROUP PLC): Industrial products and services - 'unverified' - RXST (RXSIGHT INC COM): Biotechnology, specializing in ophthalmology - 'unverified' 5. One-Sentence Style Summary: Vitruvian Partners LLP maintained its technology and health care focus, adding a new industrials position while trimming back on selected holdings, reflecting a balanced approach to active management with a sector bias towards growth sectors.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Technology 85.9%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 6.85M $111.30M 55.38%
55.38%
Hold
2 506.60K $42.05M 20.92%
20.92%
Reduce
3 181.17K $17.49M 8.70%
8.70%
Reduce
4 350.04K $11.93M 5.94%
5.94%
Reduce
5 210.21K $7.30M 3.63%
3.63%
Hold
6 5.04M $6.20M 3.09%
3.09%
Hold
7 281.28K $3.35M 1.67%
1.67%
New
8 278.87K $1.34M 0.67%
0.67%
Hold

FAQ

What did Vitruvian Partners LLP buy in 2026-Q2?

In its 2026-Q2 13F filing, Vitruvian Partners LLP reported 8 equity positions worth $200.96M in aggregate; its largest disclosed positions were MQ ($111.30M), HNGE ($42.05M), XMTR ($17.49M).

How large is Vitruvian Partners LLP's portfolio?

Vitruvian Partners LLP reported $200.96M of long equity holdings across 8 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is Vitruvian Partners LLP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/vitruvian-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →